Corrigendum to ‘Hypotonic Infant with PURA Syndrome-related Channelopathy Successfully Treated with Pyridostigmine’ Neuromuscular Disorders Volume 32, Issue 2, February 2022, Pages 166-169

The authors wish to amend the corresponding author. The corresponding author will be Dr. Stanley Iyadurai MD, PhD ([email protected]). This correction does not change any technical aspects of the manuscript. The authors thank you for your continued interest in the manuscript. Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmineNeuromuscular DisordersVol. 32Issue 2PreviewThe hypotonic infant poses a unique diagnostic dilemma owing to the multitude of possible underlying pathologies which can be divided into central and peripheral etiologies [1]. Among the many causes of peripheral hypotonia are congenital myopathies and neuromuscular junction disorders. Congenital myopathies can present with proximal muscle weakness while neuromuscular junction deficits are characterized by fluctuating neurologic symptoms and fatigability – findings usually difficult to appreciate in newborns. Full-Text PDF